Literature DB >> 8090353

Cytoskeleton and cell adhesion molecules: critical targets of toxic agents.

K R Reuhl1, L A Lagunowich, D L Brown.   

Abstract

Normal development of the nervous system depends upon complex physical interactions between cells and their local environment. These interactions are mediated by several families of cell adhesion molecules (CAMs). Differential expression and function of CAMs are operative in neural tube formation, neuron migration, in post-migratory differentiation, and maintenance of mature neural structure. CAMs also facilitate contact-dependent cell processes, such as formation of cell junctions. Temporal regulation of these molecules during development may provide "windows of vulnerability" to toxicants. In addition to their extracellular binding activities, some CAMs have membrane-spanning domains by which they communicate directly with the cytoskeleton, permitting extracellular signals to be rapidly translated into cell responses via modifications in cytoskeletal organization. These cytologic changes are particularly critical during migration, neurite formation and synaptogenesis. Toxic perturbation of adhesion molecules can have catastrophic effects on morphogenetic processes both directly and via events which depend upon cytoskeletal rearrangement. Toxicants can also act directly upon the cytoskeleton, resulting secondarily in changes of the membrane distribution and function of CAMs. Toxicant-induced changes in CAMs and cytoskeleton may occur contemporaneously. Interference of cell adhesion-cytoskeleton interactions may be a pivotal molecular event dictating developmental consequences of neurotoxicant exposure.

Mesh:

Substances:

Year:  1994        PMID: 8090353

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  3 in total

Review 1.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

2.  Therapeutic effect of the combined use of growth hormone releasing peptide-6 and epidermal growth factor in an axonopathy model.

Authors:  Diana García Del Barco; Héctor Pérez-Saad; Valia Rodríguez; Javier Marín; Viviana Falcón; Jorge Martín; Danay Cibrian; Jorge Berlanga
Journal:  Neurotox Res       Date:  2010-02-19       Impact factor: 3.911

3.  Cytoskeletal rearrangement in K562 erythroleukaemic cells forced to grow on a positively charged polymer surface.

Authors:  A Calcabrini; G Rainaldi; M T Santini
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.